Organisation paid for research Program year 2025 Source: CMS Open Payments

Sc3 Research - Pasadena

Neither a doctor nor a teaching hospital

Research payments

$34,241

8 payments

Through program year 2025, Sc3 Research - Pasadena is reported as receiving $34,241 in research payments, across 8 payments.

By program year

4 rows

Year	Kind	Amount	Payments
2025	Research	$3,600	1
2022	Research	$10,182	5
2021	Research	$500	1
2020	Research	$19,958	1

Breakdown

Who paid Research payments · program years 2020–2025

ACADIA Pharmaceuticals Inc $20,458 2 payments
AbbVie, Inc. $13,782 6 payments

Studies the money was for Research payments · program years 2020–2025

Acp-103-048 $19,958 1 payment
Study To Assess Adverse Events and Change in Disease Activity Of 24-hour Continuous Subcutaneous Infusion Of ABBV-951 In Adult Participants With Advanced Parkinsonx27s Disease $6,919 4 payments
Study To Assess Adverse Events and Change in Disease Activity Of 24-hour Continuous Subcutaneous Infusion Of ABBV-951 In Adult Participants With Advanced Parkinson Disease $3,600 1 payment
Study To Assess Adverse Events and Change in Disease Activity Of 24-hour Continuous Subcutaneous Infusion Of ABBV-951 In Adult Participants With Advanced Parkinsons Disease $3,264 1 payment
Acp-103-056 $500 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.